InvestorsHub Logo
Followers 50
Posts 3901
Boards Moderated 0
Alias Born 03/12/2011

Re: None

Monday, 01/08/2024 7:30:49 AM

Monday, January 08, 2024 7:30:49 AM

Post# of 700656
If I'm not mistaken, this month we will also see the results of the Trial with DCVax-Poli-ICLC as control and DCVax-Poli-ICLC-pembrolizumab (Keytruda).
Actually, the possible added value of Keytruda.

GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News